Crescina® Re-growth HFSC
1300 Man
Re-growth hair preparation (20 ampoules)
1300 man
It helps promote the physiological hair growth, restores and strengthens the scalp. Specific formulations for men and women. Crescina Re-Growth HFSC is a cosmetic product for topical use.
It helps promote the physiological hair growth, restores and strengthens the scalp.
Specific formulations for men and women.
Crescina Re-Growth HFSC is a cosmetic product for topical use. It contains the heart of patented Crescina Re-Growth (Cysteine, Lysine, Glycoprotein), which facilitates the physiological growth of the hair. A part of the patented active principles (Cysteine, Lysine, Glycoprotein and Stem-Engine) is inserted within specific carriers that allow for its gradual, ongoing release into the scalp (“retard” action). The proper functioning of the stem cells contained in the follicle is essential for the growth of new hair.
Recommended in cases of thinning due to physiological rather than pathological causes. Does not act on completely atrophied follicles.
CRESCINA HFSC: 100% EFFECTIVENESS IN THE SUBJECTS TESTED*
Result after 4 months of in-vivo clinical/instrumental double-blind testing, randomized and controlled with a placebo on 46 subjects (23 treated with the Crescina HFSC product and 23 with the placebo). The male subjects presented levels of thinning at grades II, III, III vertex and IV of the Hamilton-Norwood scale. All of the subjects recorded positive results from a minimum of +7 to a maximum of +41 new hairs growing in an area subject to an electronic count of 1.8 cm². The results of the test are statistically significant.
6.300 NEW HAIRS GROWING
On the basis of a mathematical analysis of the average results verified in an area of 1 cm² and extended to the whole surface of the scalp (around 600 cm²), we arrive at an average figure of 6.300 new hairs growing after 4 months of treatment with Crescina HFSC. Instrumental analysis conducted using phototrichogram.
You can consult the last Crescina® in-vivo test, published by Springer on its well renowned scientific publication, “Dermatology and Therapy”.
Androgenetic alopecia (AGA) is the most common cause of hair loss among males, characterized by progressive thinning of the scalp hairs and defined by various patterns. The main factors underling hair loss in AGA are genetic predisposition and increased sensitivity of the hair follicles to androgens, leading to a shortening of the anagen phase. In the present study, the authors investigated the efficacy of the cosmetic lotion Crescina® HFSC (human follicle stem cell; Labo Cosprophar AG, Basel, Switzerland) in promoting hair growth and in decreasing hair loss.
Re-growth hair treatment.
Promotes the physiological hair growth, restores and strengthens the scalp.
Specific formulations for men and women.
Warnings & Precautions:
The preparation shall be applied on clean and dry scalp.
It contains a mild vasodilator that may cause a slight heat reaction with reddening of the skin for a short time.
Wash hands thoroughly after the application.
A treatment of at least two months is recommended. A 3.5 ml single-dose vial should be applied daily for 5 consecutive days, followed by a two-day break, as shown in the application scheme contained in the package.
The treatment can be repeated several times a year.
Watch the video and discover how to apply Crescina HFSC – Formula 100%
https://www.youtube.com/watch?v=dj3tyUXu4go
Available in 20-vial boxes (equivalent to 1-month of treatment)
Manufactured by Labo Cosprophar AG, Basel, Switzerland.
www.labosuisse.com
Ask your pharmacist about Crescina® Re-growth HFSC
Crescina® Re-growth HFSC1300 Man
It helps promote the physiological hair growth, restores and strengthens the scalp.
Specific formulations for men and women.
Crescina Re-Growth HFSC is a cosmetic product for topical use. It contains the heart of patented Crescina Re-Growth (Cysteine, Lysine, Glycoprotein), which facilitates the physiological growth of the hair. A part of the patented active principles (Cysteine, Lysine, Glycoprotein and Stem-Engine) is inserted within specific carriers that allow for its gradual, ongoing release into the scalp (“retard” action).